REAL-LIFE LONG-TERM EFFECTIVENESS AND TREATMENT PERSISTENCE OF VEDOLIZUMAB IN A SINGLE TERTIARY CARE COHORT OF CROHN'S DISEASE PATIENTS

被引：0
|
作者：
Calandrini, L. [1 ]
Salice, M. [1 ]
Hrustemovic, Privitera H. [1 ]
Peruzzi, G. [1 ]
Rizzello, F. [1 ]
Calabrese, C. [1 ]
Scaioli, E. [1 ]
Belluzzi, A. [1 ]
Gionchetti, P. [1 ]
机构：
[1] Policlin St Orsola Malpighi, Bologna, Italy
来源：
DIGESTIVE AND LIVER DISEASE | 2020年 / 52卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
T04.01.14
引用
收藏
页码：S123 / S123
页数：1
相关论文
共 50 条
  • [21] Effectiveness and persistence of vedolizumab in patients with Inflammatory bowel Disease: Results from the Belgian REal-LIfe study with VEdolizumab (Be-RELIVE)
    Reenaers, C.
    Cremer, A.
    Dewit, O.
    de Vroey, B.
    Van Moerkercke, W.
    Bossuyt, P.
    Muls, V.
    Imschoot, J.
    Block, S.
    Hantson, A.
    Van Hootegem, P.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S476 - S477
  • [22] Effectiveness and persistence of Vedolizumab in patients with inflammatory bowel disease : results from the Belgian REal-LIfe study with VEdolizumab (Be-RELIVE)
    Reenaers, C.
    Cremer, A.
    Dewit, O.
    De Vroey, B.
    Van Moerkercke, W.
    Bossuyt, P.
    Muls, V
    Imschoot, J.
    Block, S.
    Hantson, A.
    Van Hootegem, P.
    ACTA GASTRO-ENTEROLOGICA BELGICA, 2020, 83 (01) : 15 - 23
  • [23] Real-world treatment persistence with vedolizumab in Crohn's disease and ulcerative colitis patients
    Raluy, M.
    Fraeman, K.
    Donaldson, R.
    Reynolds, M.
    Smyth, M.
    Demuth, D.
    Khalid, J. M.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S173 - S174
  • [24] Vedolizumab vs. ustekinumab for Crohn's disease: comparative effectiveness in a real-life observational cohort study (ICC case series)
    Biemans, V.
    van der Woude, C.
    van der Meulen-de Jong, A.
    Dijkstra, G.
    de Boer, N.
    Oldenburg, B.
    Ponsioen, C.
    de Vries, A.
    Wintjens, D.
    Hoentjen, F.
    Pierik, M.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S66 - S67
  • [25] Short and long-term effectiveness and safety of vedolizumab in treatment-refractory patients with ulcerative colitis and Crohn's disease - a real-world two-center cohort study
    Attauabi, Mohamed
    Vind, Ida
    Pedersen, Gitte
    Bendtsen, Flemming
    Seidelin, Jakob Benedict
    Burisch, Johan
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 33 (1S) : E709 - E718
  • [26] Short and long-term effectiveness and safety of vedolizumab in treatment-refractory patients with ulcerative colitis and Crohn's disease - a real-world two-center cohort study
    Attauabi, Mohamed
    Vind, Ida
    Pedersen, Gitte
    Bendtsen, Flemming
    Seidelin, Jakob Benedict
    Burisch, Johan
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 33 : E709 - E718
  • [27] Long-Term Efficacy of Vedolizumab Therapy for Crohn's Disease
    Hanauer, Stephen
    Rutgeerts, Paul
    Xu, Jing
    Rubin, David
    Smyth, Michael
    Abhyankar, Brihad
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2014, 109 : S479 - S479
  • [28] Effectiveness of ustekinumab in refractory Crohn's disease: A real-life experience in a tertiary referral centre
    Truyens, M.
    Geldof, J.
    Dewitte, G.
    Glorieus, E.
    Hindryckx, P.
    Ortega, T. Lobaton
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S330 - S330
  • [29] Italian real-life study evaluating the long-term effectiveness of vedolizumab for the treatment of Inflammatory Bowel Disease- An IG-IBD study
    Pugliese, D.
    Privitera, G.
    Armuzzi, A.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 823 - 824
  • [30] The Real-Life Experience of Vedolizumab Efficacy and Safety in Crohn's Disease: A Prospective Observational Multicenter Cohort Study
    Amiot, Aurelien
    Grimaud, Jean-charles
    Treton, Xavier
    Filippi, Jerome
    Pariente, Benjamin
    Peyrin-Biroulet, Laurent
    Boureille, Arnaud
    Buisson, Anthony
    Carbonnel, Franck
    Bourrier, Anne
    Nancey, Stephane
    Roblin, Xavier
    Marteau, Philippe R.
    Altwegg, Romain
    Moreau, Jacques
    Aubourg, Alexandre
    Savoye, Guillaume
    Pelletier, Anne Laure
    Fumery, Mathurin
    Bonaz, Bruno L.
    Bouhnik, Yoram
    GASTROENTEROLOGY, 2016, 150 (04) : S810 - S810
12345